Newz(NVAX) on Thursday reported a loss of $53.4 million in its second quarter. On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of 32 cents. The results beat Wall Street expectations.
The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 36 cents per share. The vaccine maker posted revenue of $56.7 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $50 million.
_____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVAX at https://www.zacks.com/ap/NVAX Source (GENB) on Thursday reported a loss of $67.3 million in its second quarter.
The Somerville, Massachusetts-based company said it had a loss of 52 cents per share. The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 48 cents per share.
The clinical-stage generative biology company posted revenue of $6.3 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $6.4 million. Access a Zacks stock report on GENB at https://www.zacks.com/ap/GENB Source
Summary from source